DNM1L and cancer: Mechanistically, SIK2 could phosphorylate Drp1 at the Ser616 site and suppress the mitochondrial OXPHOS pathway, thus suggesting that mitochondrial fission mediated by the phosphorylation of Drp1 plays an important role in impairing the OXPHOS pathway and promoting cancer development [30].